{"gene":"SYNJ1","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2013,"finding":"The R258Q mutation in the Sac1-like inositol phosphatase domain of SYNJ1 impairs the phosphatase activity of SYNJ1 against its Sac1 domain substrates in vitro, establishing that this domain has enzymatic activity toward phosphoinositide substrates.","method":"In vitro phosphatase activity assay with mutant (p.Arg258Gln) SYNJ1","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic assay, independently replicated by two labs (PMIDs 23804563 and 23804577) identifying the same mutation and functional consequence","pmids":["23804563","23804577"],"is_preprint":false},{"year":2016,"finding":"A missense variant (p.Tyr888Cys) in SYNJ1 impairs but does not abolish the dual phosphatase activity of SYNJ1 (both Sac1 and 5-phosphatase domains), while premature stop variants almost completely abolish mRNA transcript production, establishing that complete loss of dual phosphatase activity causes severe neonatal epilepsy distinct from the selective Sac1-loss parkinsonism phenotype.","method":"In vitro dual phosphatase activity assay; mRNA quantification by RT-qPCR; patient exome/genome sequencing with phenotype correlation","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro enzymatic assay with mutagenesis, two orthogonal methods (activity assay + mRNA quantification), single lab but rigorous mechanistic dissection","pmids":["27435091"],"is_preprint":false},{"year":2018,"finding":"Depletion of Synj1 causes enlargement and increased number of early endosomes, impairs recycling of transferrin (but does not alter EGF receptor trafficking), and ectopic re-expression of Synj1 rescues these defects, establishing a role for Synj1 in early endosomal homeostasis and recycling trafficking.","method":"siRNA knockdown and rescue (ectopic expression) in non-neuronal and neuronal cells; live-cell and fixed imaging of endosomal compartments; transferrin recycling assay; patient-derived fibroblast validation","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function with rescue experiment, multiple orthogonal methods (imaging + functional trafficking assay + patient fibroblasts), single lab","pmids":["29515184"],"is_preprint":false},{"year":2019,"finding":"In PARK20 (SYNJ1 p.Arg258Gln) patient fibroblasts, the ER exit machinery and ER-to-Golgi trafficking are compromised, leading to ER cargo accumulation and induction of ER stress via the PERK/eIF2α/ATF4/CHOP UPR pathway; pharmacological inhibition of PERK (GSK2606414) restores ROS levels, establishing a direct link between Synj1 loss, ER stress, and oxidative stress.","method":"Imaging and biochemical analysis of ER/Golgi morphology; UPR marker quantification; PERK inhibitor treatment with ROS measurement in PARK20 patient fibroblasts","journal":"Frontiers in neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cells with pharmacological rescue, multiple orthogonal readouts (ER morphology, UPR markers, ROS), single lab","pmids":["31316342"],"is_preprint":false},{"year":2021,"finding":"Loss of synj1 function in zebrafish disrupts ribbon synapse activity in sensory hair cells: after prolonged mechanical stimulation, phase-locking of afferent nerve activity and recovery of spontaneous synaptic vesicle release are diminished, establishing a specific role for Synj1 in sustaining sustained synaptic vesicle recycling at ribbon synapses.","method":"Zebrafish synj1 mutant analysis; vestibulospinal reflex assay; afferent nerve electrophysiology; behavioral postural control assay","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in a vertebrate model with defined cellular (ribbon synapse) and behavioral (VSR) phenotypes, single lab, multiple readouts","pmids":["33584199"],"is_preprint":false},{"year":2023,"finding":"In a Drosophila DNAJC6/Auxilin knock-in model, overexpression of Synaptojanin-1 rescues phosphoinositide lipid species alterations, synaptic dysfunction, neurological defects, and neurodegeneration caused by the DNAJC6 mutation, establishing a functional relationship between Synj1-mediated phosphoinositide metabolism and DNAJC6/Auxilin in maintaining neuronal integrity.","method":"Drosophila genetic overexpression rescue; lipidomics; neurological behavioral assays; neurodegeneration quantification","journal":"NPJ Parkinson's disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic epistasis with orthogonal lipidomic and behavioral readouts, single lab","pmids":["36739293"],"is_preprint":false},{"year":2022,"finding":"Overexpression of Synj1 in Down syndrome (DS) fetal fibroblasts recapitulates the early endosome enlargement and recycling trafficking defects observed in DS cells, suggesting that elevated Synj1 activity is sufficient to disturb early endosomal homeostasis.","method":"Synj1 overexpression in fetal fibroblasts; imaging of endosomal compartments; transferrin recycling assay; comparison to DS patient-derived fibroblasts","journal":"Frontiers in genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with phenotypic rescue comparison, multiple imaging/biochemical readouts, single lab","pmids":["35646085"],"is_preprint":false},{"year":2023,"finding":"Knockdown of synaptojanin 1 in PC12 cells reduces total and released dopamine, and SYNJ1 protein levels correlate positively with dopamine synthesis and secretion; this establishes a functional role for SYNJ1 in dopamine production and release.","method":"siRNA knockdown of SYNJ1 in PC12 cells; measurement of total and released dopamine; Western blot for protein levels","journal":"BMC genomics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method (siRNA + dopamine measurement), no mechanistic pathway placement","pmids":["37667188"],"is_preprint":false},{"year":2023,"finding":"Co-immunoprecipitation verified a physical interaction between SYNJ1 and TSP-1 (thrombospondin-1) proteins in mouse brain, with this interaction attenuated in aged hSNCA*A53T-Tg PD mice; SYNJ1 knockdown in SH-SY5Y cells reduced TSP-1 expression.","method":"Co-immunoprecipitation; transcriptomic sequencing after SYNJ1 knockdown; in silico protein-protein docking","journal":"Behavioural brain research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP with partial mechanistic follow-up, no reciprocal pulldown reported, partial in silico support","pmids":["37419331"],"is_preprint":false},{"year":2025,"finding":"BIN1 isoform 1 proximity labeling (TurboID) in mouse brain neurons identified SYNJ1 as a proximal/interacting partner of BIN1, placing SYNJ1 in the synaptic vesicle cycle network associated with BIN1 at presynaptic terminals.","method":"TurboID proximity labeling followed by label-free quantitative proteomics in mouse brain neurons; proximity ligation assay validation","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — proximity labeling identifies proximity rather than direct interaction; preprint; single lab","pmids":[],"is_preprint":true},{"year":2020,"finding":"Computational atomistic modeling of the 5-phosphatase domain of synaptojanin-1 identified its active site and its binding mode to phosphatidylinositol 4,5-bisphosphate (PIP2); membrane-embedded molecular dynamics simulations suggested that a second divalent cation is required to complete dephosphorylation, defining structural requirements for catalysis.","method":"Homology modeling; membrane-embedded molecular dynamics simulation; active-site electrostatic analysis","journal":"Computational and structural biotechnology journal","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental validation of the structural model","pmids":["32419904"],"is_preprint":false}],"current_model":"SYNJ1 encodes synaptojanin 1, a dual-domain phosphoinositide phosphatase (Sac1 + 5-phosphatase) that hydrolyzes phosphoinositide substrates at synapses to drive clathrin-coat disassembly and synaptic vesicle recycling; selective loss of Sac1 activity (R258Q) causes early-onset parkinsonism, while complete loss of dual phosphatase activity causes neonatal epileptic encephalopathy; Synj1 also governs early endosomal homeostasis and recycling trafficking, and loss of its function triggers ER stress via the PERK/UPR pathway and disrupts ribbon synapse sustainability in sensory hair cells."},"narrative":{"mechanistic_narrative":"SYNJ1 encodes synaptojanin 1, a dual-domain phosphoinositide phosphatase whose Sac1-like and 5-phosphatase activities govern phosphoinositide turnover required for membrane trafficking and synaptic function [PMID:23804563, PMID:23804577, PMID:27435091]. Genotype–phenotype dissection establishes two distinct disease mechanisms: a selective Sac1-domain mutation (R258Q) that abolishes activity against Sac1-domain substrates causes early-onset parkinsonism [PMID:23804563, PMID:23804577], whereas variants that impair or eliminate both phosphatase activities cause severe neonatal epileptic encephalopathy [PMID:27435091]. Beyond the synapse, loss of Synj1 disrupts early endosomal homeostasis, enlarging early endosomes and impairing transferrin recycling without affecting EGF receptor trafficking, defects reversible by re-expression [PMID:29515184]; conversely, Synj1 overexpression is sufficient to recapitulate these endosomal trafficking abnormalities [PMID:35646085]. In R258Q (PARK20) patient cells, compromised ER exit and ER-to-Golgi trafficking trigger ER stress through the PERK/eIF2α/ATF4/CHOP UPR pathway and elevate oxidative stress, both relieved by PERK inhibition [PMID:31316342]. Synj1 also sustains synaptic vesicle recycling at sensory hair-cell ribbon synapses [PMID:33584199] and functionally interacts with the phosphoinositide-handling machinery of DNAJC6/Auxilin to preserve neuronal integrity [PMID:36739293].","teleology":[{"year":2013,"claim":"Establishing that the Sac1-like domain is enzymatically active and that its selective inactivation underlies parkinsonism connected a specific catalytic defect to disease.","evidence":"In vitro phosphatase assay of the R258Q mutant, independently replicated by two labs","pmids":["23804563","23804577"],"confidence":"High","gaps":["Does not define in vivo Sac1-domain substrates at the synapse","Does not explain how selective Sac1 loss produces a parkinsonian phenotype mechanistically"]},{"year":2016,"claim":"Distinguishing partial dual-phosphatase impairment from near-complete loss separated the molecular basis of neonatal epileptic encephalopathy from parkinsonism, defining a dose/activity-dependent phenotypic spectrum.","evidence":"In vitro dual phosphatase assay with mutagenesis plus RT-qPCR mRNA quantification and patient sequencing","pmids":["27435091"],"confidence":"High","gaps":["Does not establish neuronal circuits affected by complete loss","Does not resolve why 5-phosphatase versus Sac1 loss produces divergent neurological outcomes"]},{"year":2018,"claim":"Demonstrating endosomal enlargement and selective transferrin recycling defects rescued by re-expression extended Synj1 function beyond the synaptic vesicle cycle to general early endosomal homeostasis.","evidence":"siRNA knockdown with rescue, endosomal imaging, transferrin recycling assay, and patient fibroblast validation","pmids":["29515184"],"confidence":"High","gaps":["Does not identify which phosphoinositide pool at endosomes is dysregulated","Does not explain cargo selectivity sparing EGFR"]},{"year":2019,"claim":"Linking R258Q to impaired ER exit and PERK/UPR-driven ER and oxidative stress provided a downstream cellular pathology connecting Synj1 loss to neurodegeneration-relevant stress responses.","evidence":"ER/Golgi morphology and UPR marker analysis with PERK inhibitor rescue of ROS in PARK20 fibroblasts","pmids":["31316342"],"confidence":"Medium","gaps":["Does not establish whether the ER trafficking defect is a direct phosphoinositide consequence","Single lab, patient-fibroblast model only"]},{"year":2021,"claim":"Showing diminished phase-locking and recovery of vesicle release at hair-cell ribbon synapses defined a specialized role for Synj1 in sustaining high-rate synaptic vesicle recycling.","evidence":"Zebrafish synj1 mutant electrophysiology and behavioral postural assays","pmids":["33584199"],"confidence":"Medium","gaps":["Does not connect ribbon synapse defects to specific phosphoinositide substrates","Mammalian relevance not tested"]},{"year":2022,"claim":"Demonstrating that Synj1 overexpression alone recapitulates endosomal trafficking defects established that dosage in both directions disturbs endosomal homeostasis, relevant to gene-dose conditions.","evidence":"Synj1 overexpression in fetal fibroblasts with endosomal imaging and transferrin recycling compared to Down syndrome cells","pmids":["35646085"],"confidence":"Medium","gaps":["Does not establish causal contribution within intact Down syndrome genetic context","Mechanism linking excess phosphatase activity to endosome enlargement unresolved"]},{"year":2023,"claim":"Genetic epistasis with DNAJC6/Auxilin showed Synj1 phosphoinositide metabolism acts in a common pathway maintaining neuronal integrity.","evidence":"Drosophila Synj1 overexpression rescue of DNAJC6 mutant lipid, synaptic, and neurodegeneration phenotypes with lipidomics","pmids":["36739293"],"confidence":"Medium","gaps":["Does not define direct biochemical coupling between Synj1 and Auxilin","Human relevance inferred from Drosophila"]},{"year":2023,"claim":"Low-confidence findings began mapping additional partners and functions, implicating Synj1 in dopamine handling and physical association with TSP-1.","evidence":"siRNA in PC12 cells with dopamine measurement; Co-IP and knockdown in brain/SH-SY5Y cells","pmids":["37667188","37419331"],"confidence":"Low","gaps":["Single-method dopamine assay without mechanistic pathway placement","TSP-1 interaction lacks reciprocal pulldown validation"]},{"year":2025,"claim":"Proximity proteomics positioned Synj1 within the BIN1-associated presynaptic vesicle cycle network.","evidence":"BIN1 TurboID proximity labeling in mouse brain neurons with PLA validation (preprint)","pmids":[],"confidence":"Low","gaps":["Proximity does not establish direct interaction","Preprint, single lab"]},{"year":null,"claim":"How the two catalytic domains differentially shape phosphoinositide pools across synaptic, endosomal, and ER compartments to produce distinct disease phenotypes remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimentally validated structure of full-length Synj1","In vivo substrate pools per domain undefined","Mechanism connecting trafficking defects to neurodegeneration not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,1,10]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,6]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,6]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4]}],"complexes":[],"partners":["DNAJC6","TSP1","BIN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43426","full_name":"Synaptojanin-1","aliases":["Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1"],"length_aa":1573,"mass_kda":173.1,"function":"Phosphatase that acts on various phosphoinositides, including phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate (PubMed:23804563, PubMed:27435091). Has a role in clathrin-mediated endocytosis (By similarity). Hydrolyzes PIP2 bound to actin regulatory proteins resulting in the rearrangement of actin filaments downstream of tyrosine kinase and ASH/GRB2 (By similarity)","subcellular_location":"Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/O43426/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SYNJ1","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SYNJ1","total_profiled":1310},"omim":[{"mim_id":"617389","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53; DEE53","url":"https://www.omim.org/entry/617389"},{"mim_id":"615530","title":"PARKINSON DISEASE 20, EARLY-ONSET; PARK20","url":"https://www.omim.org/entry/615530"},{"mim_id":"609410","title":"SYNAPTOJANIN 2; SYNJ2","url":"https://www.omim.org/entry/609410"},{"mim_id":"609287","title":"SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B1; SH3GLB1","url":"https://www.omim.org/entry/609287"},{"mim_id":"606513","title":"PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3; PACSIN3","url":"https://www.omim.org/entry/606513"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":38.6},{"tissue":"retina","ntpm":44.8}],"url":"https://www.proteinatlas.org/search/SYNJ1"},"hgnc":{"alias_symbol":["INPP5G","PARK20"],"prev_symbol":[]},"alphafold":{"accession":"O43426","domains":[{"cath_id":"-","chopping":"2-174","consensus_level":"medium","plddt":87.6534,"start":2,"end":174},{"cath_id":"-","chopping":"185-483","consensus_level":"medium","plddt":87.0561,"start":185,"end":483},{"cath_id":"3.60.10.10","chopping":"530-652_728-825_839-873","consensus_level":"high","plddt":88.7059,"start":530,"end":873},{"cath_id":"3.30.70.330","chopping":"895-970","consensus_level":"high","plddt":88.2483,"start":895,"end":970}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43426","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43426-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43426-F1-predicted_aligned_error_v6.png","plddt_mean":67.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SYNJ1","jax_strain_url":"https://www.jax.org/strain/search?query=SYNJ1"},"sequence":{"accession":"O43426","fasta_url":"https://rest.uniprot.org/uniprotkb/O43426.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43426/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43426"}},"corpus_meta":[{"pmid":"23804563","id":"PMC_23804563","title":"The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/23804563","citation_count":274,"is_preprint":false},{"pmid":"23804577","id":"PMC_23804577","title":"Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/23804577","citation_count":266,"is_preprint":false},{"pmid":"24816432","id":"PMC_24816432","title":"PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family.","date":"2014","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24816432","citation_count":99,"is_preprint":false},{"pmid":"27435091","id":"PMC_27435091","title":"Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline.","date":"2016","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27435091","citation_count":71,"is_preprint":false},{"pmid":"27496670","id":"PMC_27496670","title":"Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism.","date":"2016","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/27496670","citation_count":66,"is_preprint":false},{"pmid":"25316601","id":"PMC_25316601","title":"Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology.","date":"2014","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/25316601","citation_count":59,"is_preprint":false},{"pmid":"29515184","id":"PMC_29515184","title":"Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29515184","citation_count":57,"is_preprint":false},{"pmid":"31316342","id":"PMC_31316342","title":"PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts.","date":"2019","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31316342","citation_count":44,"is_preprint":false},{"pmid":"11443522","id":"PMC_11443522","title":"Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11443522","citation_count":44,"is_preprint":false},{"pmid":"30187305","id":"PMC_30187305","title":"A Novel SYNJ1 Mutation in a Tunisian Family with Juvenile Parkinson's Disease Associated with Epilepsy.","date":"2018","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/30187305","citation_count":31,"is_preprint":false},{"pmid":"33841314","id":"PMC_33841314","title":"Clinical Variability of SYNJ1-Associated Early-Onset Parkinsonism.","date":"2021","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33841314","citation_count":24,"is_preprint":false},{"pmid":"31751865","id":"PMC_31751865","title":"A novel homozygous SYNJ1 mutation in two siblings with typical Parkinson's disease.","date":"2019","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/31751865","citation_count":23,"is_preprint":false},{"pmid":"36739293","id":"PMC_36739293","title":"Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1.","date":"2023","source":"NPJ Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/36739293","citation_count":18,"is_preprint":false},{"pmid":"15261714","id":"PMC_15261714","title":"Analysis of SYNJ1, a candidate gene for 21q22 linked bipolar disorder: a replication study.","date":"2004","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/15261714","citation_count":18,"is_preprint":false},{"pmid":"29179256","id":"PMC_29179256","title":"SYNJ1 gene associated with neonatal onset of neurodegenerative disorder and intractable seizure.","date":"2017","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29179256","citation_count":17,"is_preprint":false},{"pmid":"26149920","id":"PMC_26149920","title":"Mutational analysis of SYNJ1 gene (PARK20) in Parkinson's disease in a Taiwanese population.","date":"2015","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/26149920","citation_count":16,"is_preprint":false},{"pmid":"30473187","id":"PMC_30473187","title":"Clonazepam improves the symptoms of two siblings with novel variants in the SYNJ1 gene.","date":"2018","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/30473187","citation_count":14,"is_preprint":false},{"pmid":"34786067","id":"PMC_34786067","title":"ln RNA LINC01234 promotes triple-negative breast cancer progression through regulating the miR-429/SYNJ1 axis.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/34786067","citation_count":14,"is_preprint":false},{"pmid":"33441699","id":"PMC_33441699","title":"MicroRNA expression profiling after recurrent febrile seizures in rat and emerging role of miR-148a-3p/SYNJ1 axis.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33441699","citation_count":10,"is_preprint":false},{"pmid":"34277811","id":"PMC_34277811","title":"RAB5C, SYNJ1, and RNF19B promote male ankylosing spondylitis by regulating immune cell infiltration.","date":"2021","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34277811","citation_count":8,"is_preprint":false},{"pmid":"32435303","id":"PMC_32435303","title":"Electroclinical Findings of SYNJ1 Epileptic Encephalopathy.","date":"2020","source":"Journal of pediatric neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/32435303","citation_count":8,"is_preprint":false},{"pmid":"26725142","id":"PMC_26725142","title":"Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism.","date":"2015","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/26725142","citation_count":7,"is_preprint":false},{"pmid":"33584199","id":"PMC_33584199","title":"Temporal Vestibular Deficits in synaptojanin 1 (synj1) Mutants.","date":"2021","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33584199","citation_count":7,"is_preprint":false},{"pmid":"35646085","id":"PMC_35646085","title":"Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35646085","citation_count":4,"is_preprint":false},{"pmid":"37419331","id":"PMC_37419331","title":"SYNJ1 rescues motor functions in hereditary and sporadic Parkinson's disease mice by upregulating TSP-1 expression.","date":"2023","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/37419331","citation_count":3,"is_preprint":false},{"pmid":"39273702","id":"PMC_39273702","title":"Identification of SYNJ1 in a Complex Case of Juvenile Parkinsonism Using a Multiomics Approach.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39273702","citation_count":3,"is_preprint":false},{"pmid":"30363595","id":"PMC_30363595","title":"Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers.","date":"2015","source":"Movement disorders clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/30363595","citation_count":2,"is_preprint":false},{"pmid":"38836947","id":"PMC_38836947","title":"Co-occurrence of PRKN and SYNJ1 variants in Early-Onset Parkinson's disease.","date":"2024","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/38836947","citation_count":2,"is_preprint":false},{"pmid":"32419904","id":"PMC_32419904","title":"Combining data integration and molecular dynamics for target identification in α-Synuclein-aggregating neurodegenerative diseases: Structural insights on Synaptojanin-1 (Synj1).","date":"2020","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/32419904","citation_count":2,"is_preprint":false},{"pmid":"37510225","id":"PMC_37510225","title":"Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37510225","citation_count":1,"is_preprint":false},{"pmid":"37667188","id":"PMC_37667188","title":"Analysis of differentially expressed genes discovers Latroeggtoxin VI-induced changes and SYNJ1 as a main target in PC12 cells.","date":"2023","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/37667188","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.19.25338055","title":"Whole-genome sequencing of 197 cases with Parkinson’s Disease reveals novel pathogenic variants in the Indian population","date":"2025-10-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.19.25338055","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.17.643635","title":"The non-catalytic ε DNA polymerase subunit is an NPF motif recognition protein","date":"2025-03-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.17.643635","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.09.642169","title":"Proteomic characterization of the Alzheimer’s disease risk factor BIN1 interactome","date":"2025-03-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.09.642169","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19336,"output_tokens":2755,"usd":0.049667,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10072,"output_tokens":3053,"usd":0.063342,"stage2_stop_reason":"end_turn"},"total_usd":0.113009,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"The R258Q mutation in the Sac1-like inositol phosphatase domain of SYNJ1 impairs the phosphatase activity of SYNJ1 against its Sac1 domain substrates in vitro, establishing that this domain has enzymatic activity toward phosphoinositide substrates.\",\n      \"method\": \"In vitro phosphatase activity assay with mutant (p.Arg258Gln) SYNJ1\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic assay, independently replicated by two labs (PMIDs 23804563 and 23804577) identifying the same mutation and functional consequence\",\n      \"pmids\": [\"23804563\", \"23804577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A missense variant (p.Tyr888Cys) in SYNJ1 impairs but does not abolish the dual phosphatase activity of SYNJ1 (both Sac1 and 5-phosphatase domains), while premature stop variants almost completely abolish mRNA transcript production, establishing that complete loss of dual phosphatase activity causes severe neonatal epilepsy distinct from the selective Sac1-loss parkinsonism phenotype.\",\n      \"method\": \"In vitro dual phosphatase activity assay; mRNA quantification by RT-qPCR; patient exome/genome sequencing with phenotype correlation\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro enzymatic assay with mutagenesis, two orthogonal methods (activity assay + mRNA quantification), single lab but rigorous mechanistic dissection\",\n      \"pmids\": [\"27435091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Depletion of Synj1 causes enlargement and increased number of early endosomes, impairs recycling of transferrin (but does not alter EGF receptor trafficking), and ectopic re-expression of Synj1 rescues these defects, establishing a role for Synj1 in early endosomal homeostasis and recycling trafficking.\",\n      \"method\": \"siRNA knockdown and rescue (ectopic expression) in non-neuronal and neuronal cells; live-cell and fixed imaging of endosomal compartments; transferrin recycling assay; patient-derived fibroblast validation\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with rescue experiment, multiple orthogonal methods (imaging + functional trafficking assay + patient fibroblasts), single lab\",\n      \"pmids\": [\"29515184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In PARK20 (SYNJ1 p.Arg258Gln) patient fibroblasts, the ER exit machinery and ER-to-Golgi trafficking are compromised, leading to ER cargo accumulation and induction of ER stress via the PERK/eIF2α/ATF4/CHOP UPR pathway; pharmacological inhibition of PERK (GSK2606414) restores ROS levels, establishing a direct link between Synj1 loss, ER stress, and oxidative stress.\",\n      \"method\": \"Imaging and biochemical analysis of ER/Golgi morphology; UPR marker quantification; PERK inhibitor treatment with ROS measurement in PARK20 patient fibroblasts\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cells with pharmacological rescue, multiple orthogonal readouts (ER morphology, UPR markers, ROS), single lab\",\n      \"pmids\": [\"31316342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of synj1 function in zebrafish disrupts ribbon synapse activity in sensory hair cells: after prolonged mechanical stimulation, phase-locking of afferent nerve activity and recovery of spontaneous synaptic vesicle release are diminished, establishing a specific role for Synj1 in sustaining sustained synaptic vesicle recycling at ribbon synapses.\",\n      \"method\": \"Zebrafish synj1 mutant analysis; vestibulospinal reflex assay; afferent nerve electrophysiology; behavioral postural control assay\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in a vertebrate model with defined cellular (ribbon synapse) and behavioral (VSR) phenotypes, single lab, multiple readouts\",\n      \"pmids\": [\"33584199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In a Drosophila DNAJC6/Auxilin knock-in model, overexpression of Synaptojanin-1 rescues phosphoinositide lipid species alterations, synaptic dysfunction, neurological defects, and neurodegeneration caused by the DNAJC6 mutation, establishing a functional relationship between Synj1-mediated phosphoinositide metabolism and DNAJC6/Auxilin in maintaining neuronal integrity.\",\n      \"method\": \"Drosophila genetic overexpression rescue; lipidomics; neurological behavioral assays; neurodegeneration quantification\",\n      \"journal\": \"NPJ Parkinson's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic epistasis with orthogonal lipidomic and behavioral readouts, single lab\",\n      \"pmids\": [\"36739293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Overexpression of Synj1 in Down syndrome (DS) fetal fibroblasts recapitulates the early endosome enlargement and recycling trafficking defects observed in DS cells, suggesting that elevated Synj1 activity is sufficient to disturb early endosomal homeostasis.\",\n      \"method\": \"Synj1 overexpression in fetal fibroblasts; imaging of endosomal compartments; transferrin recycling assay; comparison to DS patient-derived fibroblasts\",\n      \"journal\": \"Frontiers in genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with phenotypic rescue comparison, multiple imaging/biochemical readouts, single lab\",\n      \"pmids\": [\"35646085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Knockdown of synaptojanin 1 in PC12 cells reduces total and released dopamine, and SYNJ1 protein levels correlate positively with dopamine synthesis and secretion; this establishes a functional role for SYNJ1 in dopamine production and release.\",\n      \"method\": \"siRNA knockdown of SYNJ1 in PC12 cells; measurement of total and released dopamine; Western blot for protein levels\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method (siRNA + dopamine measurement), no mechanistic pathway placement\",\n      \"pmids\": [\"37667188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Co-immunoprecipitation verified a physical interaction between SYNJ1 and TSP-1 (thrombospondin-1) proteins in mouse brain, with this interaction attenuated in aged hSNCA*A53T-Tg PD mice; SYNJ1 knockdown in SH-SY5Y cells reduced TSP-1 expression.\",\n      \"method\": \"Co-immunoprecipitation; transcriptomic sequencing after SYNJ1 knockdown; in silico protein-protein docking\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP with partial mechanistic follow-up, no reciprocal pulldown reported, partial in silico support\",\n      \"pmids\": [\"37419331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BIN1 isoform 1 proximity labeling (TurboID) in mouse brain neurons identified SYNJ1 as a proximal/interacting partner of BIN1, placing SYNJ1 in the synaptic vesicle cycle network associated with BIN1 at presynaptic terminals.\",\n      \"method\": \"TurboID proximity labeling followed by label-free quantitative proteomics in mouse brain neurons; proximity ligation assay validation\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — proximity labeling identifies proximity rather than direct interaction; preprint; single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Computational atomistic modeling of the 5-phosphatase domain of synaptojanin-1 identified its active site and its binding mode to phosphatidylinositol 4,5-bisphosphate (PIP2); membrane-embedded molecular dynamics simulations suggested that a second divalent cation is required to complete dephosphorylation, defining structural requirements for catalysis.\",\n      \"method\": \"Homology modeling; membrane-embedded molecular dynamics simulation; active-site electrostatic analysis\",\n      \"journal\": \"Computational and structural biotechnology journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental validation of the structural model\",\n      \"pmids\": [\"32419904\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SYNJ1 encodes synaptojanin 1, a dual-domain phosphoinositide phosphatase (Sac1 + 5-phosphatase) that hydrolyzes phosphoinositide substrates at synapses to drive clathrin-coat disassembly and synaptic vesicle recycling; selective loss of Sac1 activity (R258Q) causes early-onset parkinsonism, while complete loss of dual phosphatase activity causes neonatal epileptic encephalopathy; Synj1 also governs early endosomal homeostasis and recycling trafficking, and loss of its function triggers ER stress via the PERK/UPR pathway and disrupts ribbon synapse sustainability in sensory hair cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SYNJ1 encodes synaptojanin 1, a dual-domain phosphoinositide phosphatase whose Sac1-like and 5-phosphatase activities govern phosphoinositide turnover required for membrane trafficking and synaptic function [#0, #1]. Genotype–phenotype dissection establishes two distinct disease mechanisms: a selective Sac1-domain mutation (R258Q) that abolishes activity against Sac1-domain substrates causes early-onset parkinsonism [#0], whereas variants that impair or eliminate both phosphatase activities cause severe neonatal epileptic encephalopathy [#1]. Beyond the synapse, loss of Synj1 disrupts early endosomal homeostasis, enlarging early endosomes and impairing transferrin recycling without affecting EGF receptor trafficking, defects reversible by re-expression [#2]; conversely, Synj1 overexpression is sufficient to recapitulate these endosomal trafficking abnormalities [#6]. In R258Q (PARK20) patient cells, compromised ER exit and ER-to-Golgi trafficking trigger ER stress through the PERK/eIF2\\u03b1/ATF4/CHOP UPR pathway and elevate oxidative stress, both relieved by PERK inhibition [#3]. Synj1 also sustains synaptic vesicle recycling at sensory hair-cell ribbon synapses [#4] and functionally interacts with the phosphoinositide-handling machinery of DNAJC6/Auxilin to preserve neuronal integrity [#5].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing that the Sac1-like domain is enzymatically active and that its selective inactivation underlies parkinsonism connected a specific catalytic defect to disease.\",\n      \"evidence\": \"In vitro phosphatase assay of the R258Q mutant, independently replicated by two labs\",\n      \"pmids\": [\"23804563\", \"23804577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not define in vivo Sac1-domain substrates at the synapse\", \"Does not explain how selective Sac1 loss produces a parkinsonian phenotype mechanistically\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Distinguishing partial dual-phosphatase impairment from near-complete loss separated the molecular basis of neonatal epileptic encephalopathy from parkinsonism, defining a dose/activity-dependent phenotypic spectrum.\",\n      \"evidence\": \"In vitro dual phosphatase assay with mutagenesis plus RT-qPCR mRNA quantification and patient sequencing\",\n      \"pmids\": [\"27435091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not establish neuronal circuits affected by complete loss\", \"Does not resolve why 5-phosphatase versus Sac1 loss produces divergent neurological outcomes\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating endosomal enlargement and selective transferrin recycling defects rescued by re-expression extended Synj1 function beyond the synaptic vesicle cycle to general early endosomal homeostasis.\",\n      \"evidence\": \"siRNA knockdown with rescue, endosomal imaging, transferrin recycling assay, and patient fibroblast validation\",\n      \"pmids\": [\"29515184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not identify which phosphoinositide pool at endosomes is dysregulated\", \"Does not explain cargo selectivity sparing EGFR\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking R258Q to impaired ER exit and PERK/UPR-driven ER and oxidative stress provided a downstream cellular pathology connecting Synj1 loss to neurodegeneration-relevant stress responses.\",\n      \"evidence\": \"ER/Golgi morphology and UPR marker analysis with PERK inhibitor rescue of ROS in PARK20 fibroblasts\",\n      \"pmids\": [\"31316342\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish whether the ER trafficking defect is a direct phosphoinositide consequence\", \"Single lab, patient-fibroblast model only\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing diminished phase-locking and recovery of vesicle release at hair-cell ribbon synapses defined a specialized role for Synj1 in sustaining high-rate synaptic vesicle recycling.\",\n      \"evidence\": \"Zebrafish synj1 mutant electrophysiology and behavioral postural assays\",\n      \"pmids\": [\"33584199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not connect ribbon synapse defects to specific phosphoinositide substrates\", \"Mammalian relevance not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that Synj1 overexpression alone recapitulates endosomal trafficking defects established that dosage in both directions disturbs endosomal homeostasis, relevant to gene-dose conditions.\",\n      \"evidence\": \"Synj1 overexpression in fetal fibroblasts with endosomal imaging and transferrin recycling compared to Down syndrome cells\",\n      \"pmids\": [\"35646085\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish causal contribution within intact Down syndrome genetic context\", \"Mechanism linking excess phosphatase activity to endosome enlargement unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Genetic epistasis with DNAJC6/Auxilin showed Synj1 phosphoinositide metabolism acts in a common pathway maintaining neuronal integrity.\",\n      \"evidence\": \"Drosophila Synj1 overexpression rescue of DNAJC6 mutant lipid, synaptic, and neurodegeneration phenotypes with lipidomics\",\n      \"pmids\": [\"36739293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not define direct biochemical coupling between Synj1 and Auxilin\", \"Human relevance inferred from Drosophila\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Low-confidence findings began mapping additional partners and functions, implicating Synj1 in dopamine handling and physical association with TSP-1.\",\n      \"evidence\": \"siRNA in PC12 cells with dopamine measurement; Co-IP and knockdown in brain/SH-SY5Y cells\",\n      \"pmids\": [\"37667188\", \"37419331\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single-method dopamine assay without mechanistic pathway placement\", \"TSP-1 interaction lacks reciprocal pulldown validation\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proximity proteomics positioned Synj1 within the BIN1-associated presynaptic vesicle cycle network.\",\n      \"evidence\": \"BIN1 TurboID proximity labeling in mouse brain neurons with PLA validation (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Proximity does not establish direct interaction\", \"Preprint, single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the two catalytic domains differentially shape phosphoinositide pools across synaptic, endosomal, and ER compartments to produce distinct disease phenotypes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimentally validated structure of full-length Synj1\", \"In vivo substrate pools per domain undefined\", \"Mechanism connecting trafficking defects to neurodegeneration not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 1, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 6]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 6]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"DNAJC6\", \"TSP1\", \"BIN1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}